4-Chloro-1,1-diethoxybutane

We are 4-Chloro-1,1-diethoxybutane CAS:6139-83-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-Chloro-1,1-diethoxybutane
CAS.NO:  6139-83-9
Synonyms:
4-chloro-1,1-diethoxybutane
4-Chlorobutyraldehyde diethyl acetal

Molecular Formula: C8H17ClO2
Molecular Weight:  180.67200

Physical and Chemical Properties:
Density:0.976g/cm3
Boiling point:208.6ºC at 760 mmHg
Melting point: /
Flash point:51.1ºC
Refractive index: 1.425

Specification:
Appearance:Colorless to light yellow transparent liquid
Purity:≥96%
Single impurity: ≤2.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Rizatriptan benzoate CAS:145202-66-0
Intermediates of Sumatriptan succinate CAS:103628-48-4
Intermediates of Sumatriptan CAS:103628-46-2

Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.2-anilino-6-dibutilamino-3-metilfluorano CAS:89331-94-2 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.693-95-8 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.2,4-difenil-7,8-dihidro-6H-quinolin-5-ona CAS:5525-40-6 Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.